Market Closed -
NSE India S.E.
05:10:48 29/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
1,008
INR
|
-1.97%
|
|
+0.20%
|
+24.20%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,04,796
|
92,044
|
1,50,529
|
1,38,013
|
1,02,795
|
1,80,489
|
-
|
-
|
Enterprise Value (EV)
1 |
1,04,796
|
94,543
|
1,44,657
|
1,34,169
|
95,949
|
1,64,823
|
1,48,916
|
1,29,568
|
P/E ratio
|
16.4
x
|
20
x
|
34.2
x
|
81.1
x
|
14.4
x
|
13.8
x
|
11.9
x
|
10.4
x
|
Yield
|
1.09%
|
1.34%
|
0.64%
|
0.6%
|
0.98%
|
0.99%
|
1.12%
|
1.15%
|
Capitalization / Revenue
|
5
x
|
4.81
x
|
7.34
x
|
7.1
x
|
3.8
x
|
4.61
x
|
4
x
|
3.64
x
|
EV / Revenue
|
5
x
|
4.94
x
|
7.05
x
|
6.9
x
|
3.54
x
|
4.21
x
|
3.3
x
|
2.61
x
|
EV / EBITDA
|
13.2
x
|
16.2
x
|
23.9
x
|
50.9
x
|
10.3
x
|
9.75
x
|
7.3
x
|
5.66
x
|
EV / FCF
|
49.4
x
|
154
x
|
327
x
|
-72.1
x
|
13.7
x
|
23.7
x
|
13.3
x
|
9.61
x
|
FCF Yield
|
2.02%
|
0.65%
|
0.31%
|
-1.39%
|
7.32%
|
4.22%
|
7.51%
|
10.4%
|
Price to Book
|
3
x
|
2.44
x
|
3.66
x
|
3.24
x
|
2.11
x
|
3.04
x
|
2.57
x
|
2.13
x
|
Nbr of stocks (in thousands)
|
1,82,746
|
1,82,068
|
1,82,338
|
1,82,520
|
1,82,470
|
1,79,110
|
-
|
-
|
Reference price
2 |
573.4
|
505.6
|
825.6
|
756.2
|
563.4
|
1,008
|
1,008
|
1,008
|
Announcement Date
|
27/05/19
|
17/06/20
|
17/06/21
|
30/05/22
|
29/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
20,945
|
19,150
|
20,521
|
19,448
|
27,071
|
39,185
|
45,132
|
49,636
|
EBITDA
1 |
7,948
|
5,826
|
6,062
|
2,635
|
9,356
|
16,899
|
20,407
|
22,912
|
EBIT
1 |
7,138
|
4,828
|
4,893
|
1,209
|
7,718
|
15,221
|
18,331
|
21,163
|
Operating Margin
|
34.08%
|
25.21%
|
23.84%
|
6.22%
|
28.51%
|
38.84%
|
40.62%
|
42.64%
|
Earnings before Tax (EBT)
1 |
8,247
|
5,687
|
5,796
|
2,022
|
8,619
|
16,001
|
18,678
|
21,651
|
Net income
1 |
6,444
|
4,608
|
4,409
|
1,700
|
7,153
|
13,212
|
15,273
|
17,622
|
Net margin
|
30.77%
|
24.06%
|
21.49%
|
8.74%
|
26.42%
|
33.72%
|
33.84%
|
35.5%
|
EPS
2 |
34.87
|
25.26
|
24.16
|
9.320
|
39.18
|
73.23
|
84.34
|
97.31
|
Free Cash Flow
1 |
2,122
|
615
|
442
|
-1,862
|
7,028
|
6,961
|
11,183
|
13,478
|
FCF margin
|
10.13%
|
3.21%
|
2.15%
|
-9.57%
|
25.96%
|
17.76%
|
24.78%
|
27.15%
|
FCF Conversion (EBITDA)
|
26.7%
|
10.56%
|
7.29%
|
-
|
75.12%
|
41.19%
|
54.8%
|
58.82%
|
FCF Conversion (Net income)
|
32.93%
|
13.35%
|
10.02%
|
-
|
98.25%
|
52.69%
|
73.22%
|
76.48%
|
Dividend per Share
2 |
6.250
|
6.750
|
5.250
|
4.500
|
5.500
|
10.02
|
11.30
|
11.60
|
Announcement Date
|
27/05/19
|
17/06/20
|
17/06/21
|
30/05/22
|
29/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
3,552
|
3,313
|
4,103
|
3,772
|
5,605
|
5,968
|
8,846
|
4,321
|
4,925
|
8,979
|
11,405
|
10,790
|
5,742
|
9,922
|
EBITDA
1 |
825
|
762
|
1,098
|
705
|
1,018
|
-186
|
3,953
|
953
|
1,059
|
3,391
|
5,280
|
4,930
|
1,284
|
4,376
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
692
|
3,504
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
12.05%
|
35.32%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
910
|
698
|
910
|
-496
|
3,858
|
-
|
814
|
3,244
|
5,000
|
4,672
|
-
|
4,732
|
Net income
1 |
627
|
530
|
750
|
651
|
804
|
-505
|
3,204
|
568
|
623
|
2,758
|
4,203
|
5,355
|
833.2
|
3,241
|
Net margin
|
17.65%
|
16%
|
18.28%
|
17.26%
|
14.34%
|
-8.46%
|
36.22%
|
13.15%
|
12.65%
|
30.72%
|
36.85%
|
49.63%
|
14.51%
|
32.67%
|
EPS
2 |
3.430
|
-
|
4.110
|
3.570
|
4.400
|
-2.770
|
17.55
|
3.110
|
3.410
|
15.11
|
23.26
|
21.42
|
3.680
|
15.00
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/02/21
|
17/06/21
|
12/08/21
|
11/11/21
|
14/02/22
|
30/05/22
|
09/08/22
|
10/11/22
|
09/02/23
|
29/05/23
|
09/08/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
2,499
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
5,872
|
3,844
|
6,846
|
15,666
|
31,573
|
50,921
|
Leverage (Debt/EBITDA)
|
-
|
0.4289
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2,122
|
615
|
442
|
-1,862
|
7,028
|
6,961
|
11,183
|
13,478
|
ROE (net income / shareholders' equity)
|
19.6%
|
12.7%
|
11.2%
|
4.05%
|
15.7%
|
24.1%
|
23.2%
|
20.3%
|
ROA (Net income/ Total Assets)
|
-
|
10.4%
|
9.4%
|
3.43%
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
44,454
|
46,898
|
49,505
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
191.0
|
207.0
|
226.0
|
234.0
|
267.0
|
332.0
|
392.0
|
474.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
4,566
|
3,558
|
2,546
|
2,327
|
1,463
|
2,692
|
2,748
|
2,697
|
Capex / Sales
|
21.8%
|
18.58%
|
12.41%
|
11.97%
|
5.4%
|
6.87%
|
6.09%
|
5.43%
|
Announcement Date
|
27/05/19
|
17/06/20
|
17/06/21
|
30/05/22
|
29/05/23
|
-
|
-
|
-
|
Last Close Price
1,008
INR Average target price
975.4
INR Spread / Average Target -3.21% Consensus |
1st Jan change
|
Capi.
|
---|
| +24.20% | 2.21B | | +26.47% | 661B | | +26.74% | 566B | | -6.33% | 352B | | +19.35% | 332B | | +4.23% | 283B | | +13.43% | 231B | | +4.71% | 200B | | -9.53% | 195B | | -4.04% | 145B |
Other Pharmaceuticals
|